Smitha Bhandari
Psychiatry · Atlanta, GANPI 1033395942
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 34.2% of the total. Reporting peaked in 2019 at $755 and has fallen 54.1% since, to $346 in 2025.
Across 143 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$960
- AbbVie$306
- Tris Pharma Inc$305
- Corium, LLC$242
- Lundbeck LLC$196
- Sunovion Pharmaceuticals Inc.$188
- plus $611 from 11 others
What the payments were for
- Food & beverage$2,804100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 43 | $960 |
| AbbVie(2 entities) | 18 | $306 |
| Tris Pharma Inc | 16 | $305 |
| Corium, LLC | 10 | $242 |
| Lundbeck LLC | 10 | $196 |
| Sunovion Pharmaceuticals Inc. | 13 | $188 |
| Ironshore Pharmaceuticals Inc. | 9 | $164 |
| Johnson & Johnson | 8 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Bausch Health US, LLC | 3 | $55 |
| Noven Therapeutics, LLC | 2 | $44 |
| Shire North American Group Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$115
How this compares
$2,808 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 28 | $310 |
| Escitalopram Oxalate | 14 | $117 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Atlanta
- David PurselleAtlanta$307K
- Michael BurkeAtlanta$217K
- Bryon EvansAtlanta$211K
- Kerry ResslerAtlanta$196K
- Patricio Riva PosseAtlanta$122K
- Ray HorwitzAtlanta$64K
- Boadie DunlopAtlanta$61K
- Zohaib HaqueAtlanta$49K
- Raymond KotwickiAtlanta$44K
- Joseph BergerAtlanta$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.